SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$17.57
-1.42 (-7.48%)
Analyst Consensus
Hold
32
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+126.5% upside
Low Target
$34.71
Average Target
$39.80
High Target
$61.57
Current Price
$17.57
Current
$17.57
$17.57
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Scenario Analysis
Bear Case
$34.71
97.6%
Low target
Base Case
$39.80
+126.5%
Avg target
Bull Case
$61.57
+250.4%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$24.68
-28.8% from high
52-Week Low
$14.68
+19.7% from low
Target vs 52W High
$39.80
+61.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |